Cordyceps Sunshine Biotech Holdings Co., Ltd. Operating Cash Flow
Cordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF) reported Operating Cash Flow of -$35.84 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-05-15.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-05-15
- Cordyceps Sunshine Biotech Holdings Co., Ltd. net cash provided by (used in) operating activities for the quarter ending 2023-12-31 was -$1.23M.
- Cordyceps Sunshine Biotech Holdings Co., Ltd. net cash provided by (used in) operating activities for the quarter ending 2022-12-31 was -$110.82K.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 8 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | -$35.84K 20-F · filed 2026-05-15 | ||||
| 2024-12-31 | $312.01K 20-F · filed 2026-05-15 | ||||
| 2023-12-31 | -$1.23M derived: 20-F 12 month − 6-K 9 month · filed 2026-05-15 | $359.72K 20-F · filed 2026-05-15 | $324.69K 20-F · filed 2024-07-05 | ||
| 2023-09-30 | $1.59M 6-K · filed 2023-11-13 | ||||
| 2022-12-31 | -$110.82K derived: 20-F/A 12 month − 6-K 9 month · filed 2025-09-23 | -$321.38K 20-F/A · filed 2025-09-23 | |||
| 2022-09-30 | -$210.56K 6-K · filed 2023-11-13 | ||||
| 2021-12-31 | -$365.36K 20-F/A · filed 2025-09-23 | ||||
| 2020-12-31 | -$130.55K 20-F · filed 2023-05-15 |